Perbedaan Indofarma Tbk. dan Panca Mitra Multiperdana Tbk.: Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M), sedangkan Panca Mitra Multiperdana Tbk. diperdagangkan di Rp50 (kapitalisasi pasar 129,42 M). Perbedaan utamanya: Indofarma Tbk. jauh lebih besar — sekitar 3× kapitalisasi pasar Panca Mitra Multiperdana Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| INAF | PMMP | |
|---|---|---|
Kapitalisasi Pasar | 390,51 M | 129,42 M |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →PT Panca Mitra Multiperdana Tbk (the Company) was established in Jakarta based on Notarial Deed No. 52 of Buntario Tigris Darmawa Ng, S.H., S.E., Candidate Notary, dated August 8, 1997. The Company commenced its commercial activity in 1997. The Company’s immediate parent company is PT Tiga Makin Jaya, which is ultimately owned by Soesilo Soebardjo.
Selengkapnya di halaman PMMP →